Sugi Predict

Sugi Predict / Compounds / SCHEMBL6097003

SCHEMBL6097003

SCHEMBL6097003

O=C(NOC1CCCCO1)C1(S(=O)(=O)N2CCC(Oc3ccc(C(F)(F)F)cc3)CC2)CCN(c2ncccn2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP13 P45452 8/20 0.41
▸ MMP2 P08253 7/20 0.41
▸ SCN9A Q15858 2/20 0.38
▸ MMP9 P14780 2/20 0.38
▸ MMP14 P50281 2/20 0.38
▸ MMP3 P08254 1/20 0.38
▸ MMP8 P22894 1/20 0.38
▸ KCNH2 Q12809 1/20 0.37
▸ SCN5A Q14524 1/20 0.37
▸ FPR2 P25090 1/20 0.37
▸ PROKR1 Q8TCW9 1/20 0.37
▸ ADRB2 P07550 1/20 0.36
▸ MMP12 P39900 1/20 0.36
▸ SLC6A7 Q99884 1/20 0.35
▸ EPHX2 P34913 1/20 0.35
▸ TP53 P04637 2/20 0.35
▸ MDM2 Q00987 2/20 0.35
▸ PRKAA2 P54646 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6098511 0.92 ACACB (0.42) MMP13MMP2SCN9AMMP9MMP14
SCHEMBL6095591 0.90 GPR119 (0.39) MMP13MMP2SCN9AMMP9MMP14
SCHEMBL6094620 0.88 MMP13 (0.43) MMP13MMP2MMP9MMP14MMP3
SCHEMBL6096034 0.86 MMP13 (0.42) MMP13MMP2MMP9MMP14MMP3
SCHEMBL6097326 0.85 MMP13 (0.51) MMP13MMP2SCN9AMMP9MMP14
SCHEMBL6098660 0.85 ADRB2 (0.48) MMP13MMP2MMP9KCNH2ADRB2
SCHEMBL6097845 0.84 ADRB2 (0.40) MMP13MMP2MMP9MMP14MMP3
SCHEMBL6095579 0.83 MMP13 (0.41) MMP13MMP2MMP9MMP14MMP3
SCHEMBL6095160 0.82 MMP13 (0.47) MMP13MMP2SCN9AMMP9MMP14
SCHEMBL6097350 0.82 MMP13 (0.47) MMP13MMP2SCN9AMMP9MMP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7067670-B2 Sulfamato hydroxamic acid metalloprotease inhibitor WARNER LAMBERT COMPANY (US) 2006-06-27 — — US disclosed
US-20050049280-A1 Sulfamato hydroxamic acid metalloprotease inhibitor PHARMACIA CORPORATION 2005-03-03 — — US disclosed
US-6800646-B1 Sulfamato hydroxamic acid metalloprotease inhibitor PHARMACIA CORPORATION 2004-10-05 — — US disclosed
US-6492367-B1 Sulfamato hydroxamic acid metalloprotease inhibitor G. D. SEARLE & COMPANY 2002-12-10 — — US disclosed
US-6448250-B1 INHIBITS THE ACTIVITY OF ONE OR MORE OF THE FOLLOWING MATRIX METALLOPROTEINASES: MMP-2, MMP-9, AND MMP-13, WHILE EXHIBITING SUBSTANTIALLY LESS INHIBITORY ACTIVITY AGAINST MMP-1 G. D. SEARLE & COMPANY 2002-09-10 — — US disclosed
EP-1157021-A1 SULFAMATO HYDROXAMIC ACID METALLOPROTEASE INHIBITOR G.D. SEARLE & CO. (US) 2001-11-28 — — EP disclosed
WO-2000046221-A1 SULFAMATO HYDROXAMIC ACID METALLOPROTEASE INHIBITOR G.D. SEARLE & CO. (US) 2000-08-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050049280-A1 Sulfamato hydroxamic acid metalloprotease inhibitor MMP14, MMP12, MMP17 MMP13 23/4885MMP2 8/4885SCN9A 2518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.